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ABSTRACT 
Backgound/Aims. We have previously reported that a complex of cadmium-metallothionein 
(Cd-MT) directly affects the apical Na-glucose cotransporter on the luminal side in proximal 
tubules, suggesting that Cd-MT is more toxic than CdCl2 in causing tubulopathy. To find 
potential mechanisms, we evaluated the effect of luminal pH alteration and carbonic 
anhydrase(CA) inhibition on Cd-MT-induced reduction of glucose-dependent transmural voltage 
in rabbit S2 segments perfused in vitro.  
Methods. Before and after the addition of Cd-MT(1μgCd/ml) to the lumen, the deflections of 
transmural voltage upon the elimination of glucose from the perfusate(ΔVtglu) were measured as 
a parameter of activity of the Na-glucose cotransporter.  
Results. During perfusion with a control solution of pH7.4, the ΔVtglu significantly decreased 
after addition of Cd-MT for 10min. A reduction of pH to 6.8 significantly shortened the time 
needed to reduce the ΔVtglu to less than 5min, whereas an increase of pH to 7.7 significantly 
prolonged the time to more than 20min. Furthermore, simultaneous addition of acetazolamide 
with control perfusate prevented the reduction. p-Fluorobenzyl-aminobenzolamide(pFB-ABZ), a 
membrane-impermeable CA inhibitor, added to the lumen also completely prevented the 
reduction of ΔVtglu. In rabbits with chronic Cd exposure, acetazolamide prevented the glucosuria.  
Conclusion. Cd-MT-induced inhibition of Na-glucose cotransporter activity in S2 segment 
strongly depends on luminal pH, and that an increase of pH by inhibition of luminal 
membrane-bound CA is useful for preventing renal Cd-toxicity. 
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Introduction 
Chronic exposure of cadmium (Cd) causes kidney injury [1]. The earliest manifestation 
of Cd nephrotoxicity is proximal tubular dysfunction such as glucosuria and aminoaciduria. 
Although the mechanisms involved in Cd-induced renal dysfunction have been extensively 
studied, detailed cellular mechanisms remain to be established. Cd in the tissue is mainly bound 
to metallothionein (MT). We have previously reported, by using an in vitro microperfusion 
technique, that Cd-MT impairs absorption of glucose from the luminal side at a very early phase 
(within 10 min after exposure) in rabbit S2 segments [2]. In that article, we found a rapid and 
possibly direct effect (within 1 min) of Cd-MT on impairment of Na-glucose cotransport activity 
as well as a late (>5 min) and more prominent effect on inhibition of Na-K-ATPase activity 
subsequent to endocytosis of Cd-MT [2]. Since the conformation of the proteins is sometimes 
altered by extrinsic pH, such a change might occur in Cd-MT by alteration of extracellular pH. If 
this is true, the Cd-induced renal toxicity might be dependent on the extracellular pH. On the 
other hand, Cd-MT complex dissociates at very low pH into Cd2+ and holo-metallothionein [3]. 
The purpose of this study was to evaluate pH dependence of the Cd-MT-induced impairment of 
glucose absorption in isolated rabbit proximal tubules perfused in vitro. We also evaluated the 
effect of carbonic anhydrase inhibitors, which increase luminal pH by reduction of H+ secretion 
in vitro and in vivo. 
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        Methods 
In Vitro Microperfusion. In vitro microperfusion of isolated renal tubules, developed by 
Burg et al. [4] , was used as modified previously [2,5-7]. Female Japanese white rabbits 
weighing 1.5–2.3 kg were maintained on regular laboratory chow and allowed free access to 
distilled water. On the day of the experiments, animals were anesthetized with sodium 
pentobarbital (35 mg/kg, i.v.). The left kidney was removed, and coronal slices were made. 
Slices were transferred to a chilled dish containing modified Collins’ solution of the following 
composition: 14 mM KH2PO4, 44 mM K2HPO4, 15 mM KCl, 9 mM NaHCO3, and 160 mM 
sucrose, with pH maintained at 7.4. Segments of proximal tubules (S2), with length ranging from 
0.8 to 1.2 mm, were isolated from the medullary ray of renal cortex by fine forceps under a 
stereomicroscope. Isolated tubules were transferred to the perfusion chamber mounted on an 
inverted microscope (IX-71, Olympus, Tokyo, Japan) and perfused in vitro at 37°C. Tubules 
were hooked up to the holding pipette, and a single-barreled perfusion pipette was inserted into 
the tubular lumen. Triple-barreled polyethylene tubing was inserted into the perfusion pipette to 
allow rapid exchange of the perfusion fluid. The perfusion rate was controlled at 10–20 nl/min 
by adjusting the height of the fluid reservoir, which was connected to the back end of the 
perfusion pipette. A system of a flow-through bath was used to permit rapid exchange of the 
bathing fluid. The bathing fluid was maintained at 37°C by using a warm water jacket. The flow 
rate of the bathing fluid ranged from 3 to 5 ml/min, allowing the bath fluid to be exchanged 
within 2 sec. The composition of the basal solution used in this study was as follows: 110 mM 
NaCl, 5 mM KCl, 25 mM NaHCO3, 0.8 mM Na2HPO4, 0.2 mM NaH2PO4, 10 mM sodium 
acetate, 1.8 mM CaCl2, 1.0 mM MgCl2, 8.3 mM glucose, and 5 mM alanine. The pH of the 
solution was maintained at 37°C by bubbling with 95% O2, 5% CO2 gas. In some experiments, 
bicarbonate-free HEPES buffer solution with the following composition was used: 110 mM NaCl, 
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5 mM KCl, 25 mM Na-cyclamate, 10 mM HEPES, 5 mM Tris, 0.8 mM Na2HPO4, 0.2 mM 
NaH2PO4, 10 mM sodium acetate, 1.8 mM CaCl2, 1.0 mM MgCl2, 8.3 mM glucose, and 5 mM 
alanine.  
Electrophysiological Studies. Transmural voltage (Vt) was measured by connecting a 
1-M KCl agar bridge to a saturated KCl reservoir, where a calomel half-cell electrode was placed. 
The electrode was connected to a dual-channel electrometer (Duo 773, W.P. Instruments, New 
Haven, CT), and measured voltage was recorded on a two-pen recorder (R301, Rikadenki, Tokyo, 
Japan). A flowing-boundary 1M KCl agar bridge connected to a calomel half-cell was placed at 
the outflow of the bath and served as a ground. The deflection of apical membrane voltage on 
abrupt elimination of glucose from the luminal fluid reflects activity of Na+-dependent glucose 
cotransporter in the apical membrane [8,9]. Because we have previously confirmed that 
deflection of Vt on abrupt elimination of glucose from the luminal fluid (ΔVtglu) moves in parallel 
with the deflection of apical membrane voltage on abrupt elimination of glucose from the 
luminal fluid by simultaneous recording [2], we used ΔVtglu as a parameter of the Na-glucose 
cotransporter activity, instead of the apical membrane voltage on abrupt elimination of glucose 
from the luminal fluid, in this study. The ΔVtglu was measured before and, 10 and 20 min. after 
addition of Cd-MT (10–6g Cd/ml) to lumen. This dose is comparable to that of chronic Cd 
exposure in rabbit plasma [12].  
Net Bicarbonate Transport. The concentrations of inulin and total CO2 (assumed to be 
equal to that of HCO3) in perfusate and collected fluid were measured in a continuous-flow 
microfluorometer (Nanoflo, WPI, Sarasota, FL) [10]. Three 47-nl collections were made per 
period and stored under water-saturated mineral oil. Aliquots (15 nl) of each collection were 
analyzed for total CO2 on the day of the experiment and for inulin on the following day, using 
procedures specified by the manufacturer [11]. Samples of perfusate were processed similarly. 
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The perfusion rate was generally 5–8 nl/min. The HCO3 transport rate (JHCO3) was calculated as 
 
JHCO3 = (Vi  [HCO3]i – Vo [HCO3]o)/L, 
 
where Vi and Vo are perfusion rate and collection rate, respectively, [HCO3]i and [HCO3]o are 
HCO3 concentrations in the perfusate and collected fluid, respectively, and L is tubular length in 
millimeters. Positive values of JHCO3 indicate net HCO3 absorption. 
In Vivo Study. Female Japanese white rabbits weighing 1.5–2.2 kg (n = 23) were used. 
They had free access to standard chow (CR-3, Nippon Crea containing 0.06 μg Cd/g, 7 μg Cu/g, 
31 μg Zn/g, 392 μg Fe/g, and 20.3 mg Ca/g) and distilled water until the end of the study. They 
were kept in the standard animal room in our medical school, with a 12-h light/dark cycle. The 
temperature and humidity were maintained automatically. CdCl2 (0.3 mg Cd /Kg, s.c. once every 
day) [12] and/or acetazolamide (ACZ, 2 mg/kg for low dose and 20 mg/kg for high dose, i.p. 
twice daily) were given for 8 weeks to the rabbits. The rabbits consisted of the following four 
groups: Group 1 (n = 5): vehicle; Group 2 (n = 6): CdCl2; Group 3 (n = 6): CdCl2 + ACZ (2 
mg/kg); Group 4 (n = 6): CdCl2 + ACZ (20 mg/kg). 
Blood and 1-day urine samples were obtained before and 4 and 8 weeks after the 
treatment. The urine was collected by using a metabolic cage. Plasma and urine creatinine (Cr) 
were measured by modified Jaffe’s reaction with autoanalyzer. Urine glucose concentration was 
measured by Glucose FA test (Wako Pure Chemicals, Osaka, Japan) with autoanalyzer (Abbott 
VP, Abbott Park, Illinois, USA) and expressed as the ratio to creatinine concentration [12]. The 
Cd-MT in the urine specimen was fractionized by high-performance gel-filtration column (Toyo 
soda, HLC-803A, Tokyo, Japan) and Cd concentration was measured by flameless atomic 
absorption spectrophotometer (Hitachi Z 9000, Tokyo, Japan) after dilution with nitric acid [12].  
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Chemicals. All solutions containing bicarbonate were bubbled with 95% O2, 5% CO2 gas 
to adjusted pH of 7.4. The pH of HEPES solution was adjusted by addition of Tris. All reagents, 
except p-fluorobenzyl-aminobenzolamide, were purchased from Sigma (St. Louis,, USA). 
p-Fluorobenzyl-aminobenzolamide (pFB-ABZ), a carbonic anhydrase inhibitor impermeable to 
the cell membrane [11,13], was synthesized by the method of Tewson et al. [13]. Concentration 
of Cd-MT was expressed as grams of Cd per milliliter to represent Cd concentration contained in 
the molecule. 
Ethical aspect. All of the experiments shown in this study were performed according to the 
Guidelines of Animal Research of our medical school, which thoroughly incorporated the 
National Guideline of Animal Research of Japan. 
Statistics. All data were expressed as means ± SE. Statistical comparison was performed 
using Student’s t-test and ANOVA, where appropriate; p values less than 0.05 were regarded as 
significant. 
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Results 
pH Dependence of Acute Effect of Luminal Cd-MT on ΔVtglu. First, we evaluated the 
effect of luminal pH on ΔVtglu after luminal Cd-MT using HEPES buffer solution. As shown in 
Fig. 1, the ΔVtglu significantly decreased within 10 min after addition of Cd-MT (10–6g Cd/ml) 
when the luminal pH was 7.4 (mean ΔVtglu before and 10 min after addition of Cd-MT = 2.0 ± 
0.1 mV and 0.5 ± 0.1 mV, respectively; n = 17). The time needed to cause the change was 
slightly but significantly slower than in our previous report, in which we used bicarbonate buffer 
solution with the same pH [2]. When the pH of the perfusate was decreased to 6.8, the reduction 
of ΔVtglu was significantly accelerated, whereas it was prolonged when the pH was changed to 
7.7 (Fig. 1). The ΔVtglu was maintained at a similar level for at least 20 min when Cd-MT was 
not added in the pH 6.8 and 7.7 solutions :ΔVtglu before and 20 min after the experiments was 1.9 
± 0.2 mV and 1.8 ± 0.2 mV at pH6.8, and 2.0 ± 0.2 mV and 1.9 ± 0.2 mV at pH7.7, respectively; 
n = 4 in each. 
Effect of Carbonic Anhydrase Inhibitors on Cd-MT-Induced ΔVtglu. Because the 
effect of luminal Cd-MT on ΔVtglu was dependent on luminal pH, we next examined the effect of 
carbonic anhydrase (CA) inhibitors, which alter luminal pH in a bicarbonate buffer solution. As 
shown in Fig. 2A, luminal Cd-MT (10–6g Cd/ml) almost completely suppressed ΔVtglu within 10 
min after addition, whereas the vehicle did not show any effects (Fig 2B), confirming our 
previous observation [2]. We also found that comparable concentration of native MT itself did 
not affect to ΔVtglu (ΔVtglu before and 20 min after addition of MT was 2.0 ± 0.3 mV and 1.8 ± 
0.3 mV at pH7.4, P>0.05). When 10–5 M ACZ was added to the lumen, luminal administration of 
Cd-MT did not cause any inhibition of ΔVtglu, and subsequent elimination of ACZ from the 
lumen caused marked inhibition of ΔVtglu (Fig. 3A). On the other hand, administration of ACZ to 
the bath did not prevent the inhibitory effect of Cd-MT on ΔVtglu (Fig. 3B). 
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To confirm that the observed effect of ACZ is due to inhibition of membrane-bound CA, 
rather than intracellular CA, we tested effects of pFB-ABZ, an impermeable inhibitor 
specifically restricted in its binding to membrane-bound CA [11,13]. Luminal pFB-ABZ (10–5 M) 
completely prevented the decrease of Cd-MT-induced ΔVtglu, and this effect was reversed by 
elimination of the drug from the lumen (Fig. 4A). Once Cd-MT decreased ΔVtglu, it was not 
recovered by addition of pFB-ABZ (Fig. 4B). Furthermore, addition of CA (2 mg/dl) in 
combination with pFB-ABZ reversed the preventive effect of pFB-ABZ against Cd-MT (Fig. 
5A). CA alone did not affect the ΔVtglu (Fig. 5B). When pFB-ABZ was added to the bath, it did 
not prevent the change of ΔVtglu by luminal Cd-MT (Fig. 6). 
Effect of Luminal Carbonic Anhydrase Inhibitors on Bicarbonate Transport. JHCO3 
decreased from 68.2 ± 3.4 to 33.4 ±3.7 pmol/min/mm by addition of pFB-ABZ to lumen (n = 4, 
P<0.01), which is consistent with our previous study [11]. Luminal ACZ also reduced 
bicarbonate absorption from 70.8 ± 3.1 to 37.0 ± 4.7 pmol/min/mm (n = 4, P<0.01). These 
results indicated that pFB-ABZ and ACZ to lumen prevented absorption of bicarbonate and 
consequently prevented reduction of luminal pH in vitro. 
Effect of Modulator of Cytoskeleton on Cd-MT-Induced Dysfunction of the 
Proximal Tubule. Since the pH-dependent effect of Cd-MT was time-dependent rather than 
instantaneous (Fig. 1), the effect might not be a direct one on Na+-glucose cotransporter. It is 
possible that Cd-MT exerts the inhibitory effect after intracellular uptake of the complex. To 
evaluate this possibility, we examined the effect of cytoskeleton modulators. Pretreatment with 
colchicine (10–5 M) from lumen prevented the reduction of Cd-MT-induced reduction of ΔVtglu, 
(Fig 7A), whereas lumicolchicine, a biologically inactive colchicine analogue, did not prevent it 
(Fig. 7B). Cytochalasin D (10–6 M) (Fig. 8A) and Y-27632 (10–4 M) (Fig. 8B), an inhibitor of 
rho-kinase [14], also prevented the Cd-MT induced reduction. 
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In Vivo Effect of ACZ in Preventing Cd-Induced Nephrotoxicity. Repeated 
administration of Cd caused nephrotoxicity as revealed by increased serum creatinine (Cr) 
concentration and urinary excretion of glucose. The renal Cd toxicity represented by these data 
was prevented by administration of ACZ in a dose-dependent manner (Fig. 9A, B). Urinary 
Cd-MT content at the end of the study was significantly increased by co-administration with 
high-dose of acetazolamide, bur not by low dose (Fig. 9C). Body weights did not decrease in 
either group (data not shown). 
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Discussion 
The present study demonstrates in rabbit proximal tubule cells that the inhibitory effect of 
Cd-MT on ΔVtglu is pH-depndent: an increase of luminal pH prevented, and a decrease of the pH 
worsened, the impairment of sodium-dependent glucose transporter activity following acute 
luminal exposure of Cd-MT. This is the first study showing that the impairment of 
sodium-dependent glucose transporter activity by luminal Cd-MT is dependent on luminal pH. 
We observed that the reduction of bicarbonate absorption was prevented by luminal pFB-ABZ 
and ACZ in this study. Because luminal pH decreased along the proximal tubule by reabsorption 
of bicarbonate in the filtered fluid, the reduction of bicarbonate absorption by pFB-ABZ and 
ACZ to lumen inhibited the reduction of luminal pH. Therefore a preventive effect of pFB-ABZ 
and ACZ on Cd-MT-induced toxicity was mediated by an increase of luminal pH. The luminal 
pH in the normal kidney can be changed from about 6.8 to 7.7 to adapt to the systemic acid-base 
status [15]. Thus it is important to note that the prevention of the toxic effect of Cd-MT is 
attainable within physiological range of the luminal pH in the proximal tubule. 
Inhibition of carbonic anhydrase in the cytosol and/or apical membrane of proximal 
tubule cells prevented the reduction of luminal pH and decreased urinary acid excretion [15]. 
Therefore the prevention of the Cd-MT-induced damage by acetazolamide and pFB-ABZ in this 
study must be due to alteration of luminal pH by these drugs. We also found that the effects of 
luminal ACZ and pFB-ABZ, a CA inhibitor impermeable to cell membrane but able to affect 
HCO3– absorption in proximal tubule cells [11], were comparable, while basolateral addition of 
ACZ was not effective. These results suggest that inhibition of luminal membrane-bound CA is 
important for preventing the Cd-MT-induced damage. Among many isoforms of CA, CA IV, XII, 
XIV, and XV are membrane-associated and reported to be located in kidney, while CA XIV is not 
detected in the rabbit, while it is detected in mouse kidney [16,17].  
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It is uncertain how alteration of luminal pH affects the toxicity of Cd-MT. It is generally 
believed that Cd-MT enters the cell as Cd-MT and dissociates into Cd2+ in the cytoplasm. 
Alteration of luminal pH will mainly affect the phenomenon in the lumen. Therefore 
conformational change of Cd-MT in the luminal space by an increase of pH reduces the transport 
of luminal Cd-MT into the cell. It is also possible that carrier protein of Cd-MT in the apical 
membrane might be reduced in its activity by an increase of luminal pH. It is reported that 
endocytosis of Cd-MT is mediated by megalin [18,19] and that the expression of megalin is 
reduced by Cd-MT exposure [20]. However, the influence of intracellular pH on activity of 
megalin was not reported. Another possibility is that the increase of luminal pH directly 
enhances glucose transporter activity. We think that this may not be true because we have some 
preliminary data that ΔVtglu was maintained at a similar level for at least 20 min when Cd-MT 
was not added in pH 6.8 and 7.7 solutions. 
We found that modifiers or modulators of cytoskeleton (such as colchicine, cytochalasin 
D) and rho-kinase inhibitor Y-27632 prevented Cd-MT-induced functional damage. This may be 
compatible with the finding that endocytosis was reduced in renal tubular cells from Cd-treated 
animals [21]. It was reported that inhibition of acidic endocytotic compartments by chloroquine, 
or LY294002, prevented Cd-MT-induced apoptosis [22]. Alkalinization of luminal fluid may 
secondarily alter intracellular pH, which subsequently affects the endosomal uptake of 
Cd/Cd-MT. 
We also found that the time needed to reduce ΔVtglu after addition of luminal Cd-MT was 
slightly but significantly increased in HEPES buffer solution than in a bicarbonate buffer 
solution of similar pH. The reason for this difference is uncertain at the present time. HEPES is 
not membrane-permeable and is less likely to affect intracellular pH than bicarbonate, which 
may affect the results. It may suggest the existence of other factor(s) beside pH contributing to 
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the Cd-MT-induced damage.  
Based on the in vitro data as discussed above, we propose that the inhibition of CA would 
be a therapeutic option for the prevention of Cd-induced nephropathy. This is another important 
feature of this study. The in vivo experiments were designed to support this issue. Although we 
did not examine detailed kidney functions such as clearance studies, both plasma creatinine 
levels and glucosuria are reasonable parameters to represent Cd nephrotoxicity. Under chronic 
experimental conditions in the in vivo study, we think that glucosuria is one of the parameters of 
nephrotoxicity rather than simple alteration of the cotransporter. The data clearly support the 
notion that administration of ACZ prevents Cd-induced nephrotoxicity in a dose dependent 
manner. Our in vivo data is compatible with the findings of a previous article by Nomiyama et 
al [12], although their interpretation of this effect was somewhat different. CA inhibitors are 
mainly used as diuretics, but not commonly used for prevention of nephrotoxicity. From this 
point of view, the present data are unique. We also found that urinary excretion of Cd-MT 
increased by high dose of acetazolamide, which supported for the relationship between in vivo 
and in vitro data. Low dose of acetazolamide did not increase the Cd-MT excretion. We think 
that this model of chronic intoxication excreted very large amount of Cd-MT into urine, and the 
low dose of acetazolamide may not be enough for in vivo treatment. We have previously reported 
that alkalinization of systemic pH by addition of citrate prevented cyclosporine-A-induced distal 
renal tubular acidosis in rats [23]. Acetazolamide might also be used for prevention of the 
cyclosporine-A-induced damage.  
Nomiyama et al [12] previously reported in the rabbit that nephrotoxicity by systemic Cd 
exposure was also prevented by the addition of glycyrrhizic acid, the active pharmacological 
ingredient of licorice. They speculated that glycyrrhizic acid prevented the release of Cd-MT 
from the liver into systemic circulation because of its protective effect on hepatic functions. The 
 14
glycyrrhizic acid, however, was also reported to cause pseudo-aldosteronism, which 
subsequently causes metabolic alkalosis [24]. Therefore it is necessary to examine whether effect 
of glycyrrhizic acid was due to an increase of systemic pH by the drug. 
Recently, it was reported that expression of NHE3 protein decreased while CA IV was 
unchanged in brush border membrane vesicles from renal proximal tubule cells in Cd-intoxicated 
rats. These results indicate that urinary alkalinization will occur in Cd intoxication [25]. We did 
not evaluate Na-H exchanger activity in this study. Because our finding indicates that 
alkalinization of luminal fluid prevented the Cd-MT-induced toxicity, the reduction of NHE3 
protein may be an adaptive response of the kidney to prevent the damage of proximal tubule 
cells. 
In summary, we found for the first time that the impairment of sodium-dependent glucose 
transporter activity caused by luminal Cd-MT is influenced by luminal pH and that an increase in 
pH prevented the impairment in isolated perfused rabbit proximal tubules. We also found that 
inhibition of luminal CA activity, which increases the luminal pH, also prevented the impairment. 
Addition of cytoskeleton modifiers also prevented the toxicity. Furthermore, administration of 
acetazolamide in vivo also prevented the nephrotoxicity of Cd exposure. These results may point 
to new therapy options in preventing the nephrotoxicity of systemic Cd exposure. 
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Figure legends 
Fig. 1. pH-dependent effect of luminal Cd-MT on glucose-induced Vt deflection. Values are 
given as Mean ± SE. *p < 0.05 vs. pH 7.4 by repeated ANOVA; n = 4–17 in each. Abbreviation: 
Pre ; pretreatment period/ The same are applied for all other figures. 
 
Fig. 2. Comparison of the effects of luminal Cd-MT (A) and vehicle (B) at pH7.4 on 
glucose-induced Vt deflection.  Time courses of glucose-induced Vt deflection are shown. 
Individual results and mean ± SE are also shown. *p < 0.05 vs. pre.  
 
Fig. 3. Comparison of effect of ACZ added to the lumen (A) and to the bath (B). Luminal 
addition of ACZ for 10 min prevented the suppression of the glucose-induced Vt deflection 
caused by luminal Ca-MT, and removal of ACZ reversed the effect (A). Administration of ACZ 
to the bath was without any effect (B). Individual results and mean ± SE are also shown. *p < 
0.05 vs. Pre.  
 
Fig. 4. Effect of luminal p-fluorobenzyl-aminobenzolamide (pFB-ABZ) for 10 min on 
Cd-MT-induced reduction of Vt deflection upon glucose removal: (A) pFB-ABZ added from 
zero to 10 min. (B) pFB-ABZ added from 10 to 20 min. Individual results and mean ± SE are 
also shown. *p < 0.05 vs. Pre. 
 
Fig. 5. (A) carbonic anhydrase reverses the protective effect of pFB-ABZ on Cd-MT inhibition 
of glucose-dependent Vt deflection. (B) carbonic anhydrase alone had no effect. Individual 
results and mean ± SE are also shown. *p < 0.05 vs. Pre. 
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Fig. 6. No effect of basolateral p-fluoro benzolamide (pFB-ABZ) on Cd-MT-induced reduction 
of Vt deflection upon glucose removal. Individual results and mean ± SE are also shown. *p < 
0.05 vs. pre. 
 
Fig. 7. (A) Effect of colchicine on Cd-MT-induced reduction of Vt deflection upon glucose 
removal. (B) lumicolchicine had no effect. Individual results and mean ± SE are also shown. *p 
< 0.05 vs. pre. 
 
Fig. 8. Effects of cytochalasin D (A) and Y-27632 (B) on Cd-MT-induced reduction of Vt 
deflection upon glucose removal. Individual results and mean ± SE are also shown. 
 
Fig. 9. Effect of ACZ on CdCl2-induced renal dysfunction in vivo. Mean ± SE. *p < 0.05 vs. 
CdCl2. Nephrotoxicity of CdCl2 was represented by plasma creatinine (A), glucosuria (B) 
concentrations. Urinary Cd-MT (C) excretion at eight week after the study was increased by high 
dose of acetazolamide than CdCl2 group. 
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